These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


358 related items for PubMed ID: 11106100

  • 1. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
    Jia DM, Tabaru A, Akiyama T, Abe S, Otsuki M.
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Troglitazone ameliorates abnormal activity of protein tyrosine phosphatase in adipose tissues of Otsuka Long-Evans Tokushima Fatty rats.
    Tagami S, Honda T, Yoshimura H, Homma H, Ohno K, Ide H, Sakaue S, Kawakami Y.
    Tohoku J Exp Med; 2002 Jul; 197(3):169-81. PubMed ID: 12365558
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
    Kosegawa I, Chen S, Awata T, Negishi K, Katayama S.
    Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
    [Abstract] [Full Text] [Related]

  • 9. Disordered expression of the sucrase-isomaltase complex in the small intestine in Otsuka Long-Evans tokushima fatty rats, a model of non-insulin-dependent diabetes mellitus with insulin resistance.
    Adachi T, Takenoshita M, Katsura H, Yasuda K, Tsuda K, Seino Y, Enomoto T, Yamaji R, Miyatake K, Inui H, Nakano Y.
    Biochim Biophys Acta; 1999 Jan 04; 1426(1):126-32. PubMed ID: 9878708
    [Abstract] [Full Text] [Related]

  • 10. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats.
    Jia DM, Fukumitsu KI, Tabaru A, Akiyama T, Otsuki M.
    Am J Physiol Regul Integr Comp Physiol; 2001 May 04; 280(5):R1332-40. PubMed ID: 11294751
    [Abstract] [Full Text] [Related]

  • 11. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
    Kumar S, Prange A, Schulze J, Lettis S, Barnett AH.
    Diabet Med; 1998 Sep 04; 15(9):772-9. PubMed ID: 9737807
    [Abstract] [Full Text] [Related]

  • 12. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
    Jia D, Yamamoto M, Otani M, Otsuki M.
    Metabolism; 2004 Apr 04; 53(4):405-13. PubMed ID: 15045684
    [Abstract] [Full Text] [Related]

  • 13. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK, Zhao ZS, Lee YJ, Lee KE, Kang SM, Choi D, Lim SK, Chung N, Lee HC, Cha BS.
    Diabetes Metab Res Rev; 2003 Apr 04; 19(6):487-93. PubMed ID: 14648808
    [Abstract] [Full Text] [Related]

  • 14. Effect of obesity and troglitazone on expression of two glutathione peroxidases: cellular and extracellular types in serum, kidney and adipose tissue.
    Asayama K, Nakane T, Dobashi K, Kodera K, Hayashibe H, Uchida N, Nakazawa S.
    Free Radic Res; 2001 Apr 04; 34(4):337-47. PubMed ID: 11328671
    [Abstract] [Full Text] [Related]

  • 15. Dietary troglitazone decreases oxidative stress in early stage type II diabetic rats.
    Fukui T, Noma T, Mizushige K, Aki Y, Kimura S, Abe Y.
    Life Sci; 2000 Apr 14; 66(21):2043-9. PubMed ID: 10823344
    [Abstract] [Full Text] [Related]

  • 16. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.
    Hosomi N, Noma T, Ohyama H, Takahashi T, Kohno M.
    Atherosclerosis; 2002 May 14; 162(1):69-76. PubMed ID: 11947899
    [Abstract] [Full Text] [Related]

  • 17. Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors.
    Yamagishi T, Saito Y, Nakamura T, Takeda S, Kanai H, Sumino H, Kuro-o M, Nabeshima Y, Kurabayashi M, Nagai R.
    Hypertens Res; 2001 Nov 14; 24(6):705-9. PubMed ID: 11768731
    [Abstract] [Full Text] [Related]

  • 18. Effects of obesity and inheritance on the development of non-insulin-dependent diabetes mellitus in Otsuka-Long-Evans-Tokushima fatty rats.
    Okauchi N, Mizuno A, Zhu M, Ishida K, Sano T, Noma Y, Shima K.
    Diabetes Res Clin Pract; 1995 Jul 14; 29(1):1-10. PubMed ID: 8593753
    [Abstract] [Full Text] [Related]

  • 19. Increased lymphatic lipid transport in genetically diabetic obese rats.
    Hayashi H, Sato Y, Kanai S, Ichikawa M, Funakoshi A, Miyasaka K.
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan 14; 282(1):G69-76. PubMed ID: 11751159
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan 14; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.